全文获取类型
收费全文 | 914篇 |
免费 | 52篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 6篇 |
儿科学 | 24篇 |
妇产科学 | 20篇 |
基础医学 | 99篇 |
口腔科学 | 16篇 |
临床医学 | 66篇 |
内科学 | 216篇 |
皮肤病学 | 23篇 |
神经病学 | 42篇 |
特种医学 | 86篇 |
外科学 | 103篇 |
综合类 | 32篇 |
预防医学 | 49篇 |
眼科学 | 17篇 |
药学 | 73篇 |
中国医学 | 11篇 |
肿瘤学 | 89篇 |
出版年
2023年 | 5篇 |
2022年 | 11篇 |
2021年 | 20篇 |
2020年 | 11篇 |
2019年 | 17篇 |
2018年 | 30篇 |
2017年 | 24篇 |
2016年 | 18篇 |
2015年 | 21篇 |
2014年 | 34篇 |
2013年 | 48篇 |
2012年 | 51篇 |
2011年 | 59篇 |
2010年 | 36篇 |
2009年 | 44篇 |
2008年 | 51篇 |
2007年 | 54篇 |
2006年 | 38篇 |
2005年 | 44篇 |
2004年 | 29篇 |
2003年 | 20篇 |
2002年 | 37篇 |
2001年 | 23篇 |
2000年 | 11篇 |
1999年 | 15篇 |
1998年 | 20篇 |
1997年 | 27篇 |
1996年 | 18篇 |
1995年 | 11篇 |
1994年 | 5篇 |
1993年 | 9篇 |
1990年 | 7篇 |
1989年 | 9篇 |
1988年 | 10篇 |
1987年 | 11篇 |
1986年 | 10篇 |
1985年 | 21篇 |
1984年 | 9篇 |
1983年 | 3篇 |
1982年 | 7篇 |
1981年 | 7篇 |
1980年 | 6篇 |
1979年 | 2篇 |
1978年 | 3篇 |
1977年 | 2篇 |
1976年 | 4篇 |
1975年 | 3篇 |
1973年 | 4篇 |
1968年 | 3篇 |
1961年 | 2篇 |
排序方式: 共有972条查询结果,搜索用时 31 毫秒
871.
W Struhal M Guger S Hödl SC Ung M Bach G Ransmayr 《Wiener klinische Wochenschrift》2012,124(13-14):461-463
Impulse control disorder during continuous subcutaneous apomorphine treatment (CAI) was recently reported. We describe a 54-year-old patient with familial Parkinson's disease, who after initiation of CAI in addition to high dose levodopa and amantadine, developed impulse control disorder (major financial loss related to risky transactions and self-medication), psychosis and depression, which lead up to attempted suicide. To our knowledge, this is the first case of attempted suicide under apomorphine treatment. 相似文献
872.
873.
Xi Xiaoyu Huang Yuankai Lu Qianni Ung Carolina Oi Lam Hu Hao 《International journal of clinical pharmacy》2019,41(2):478-487
International Journal of Clinical Pharmacy - Background Whether Chinese community pharmacists in chain pharmacies and independent pharmacies provide the same type and quality of pharmaceutical care... 相似文献
874.
875.
M. Rejab J. H. D. Wong Z. Jamalludin W. L. Jong R. A. Malik W. Z. Wan Ishak N. M. Ung 《Australasian physical & engineering sciences in medicine / supported by the Australasian College of Physical Scientists in Medicine and the Australasian Association of Physical Sciences in Medicine》2018,41(2):475-485
This study investigates the characteristics and application of the optically-stimulated luminescence dosimeter (OSLD) in cobalt-60 high dose rate (HDR) brachytherapy, and compares the results with the dosage produced by the treatment planning system (TPS). The OSLD characteristics comprised linearity, reproducibility, angular dependence, depth dependence, signal depletion, bleaching rate and cumulative dose measurement. A phantom verification exercise was also conducted using the Farmer ionisation chamber and in vivo diodes. The OSLD signal indicated a supralinear response (R2?=?0.9998). It exhibited a depth-independent trend after a steep dose gradient region. The signal depletion per readout was negligible (0.02%), with expected deviation for angular dependence due to off-axis sensitive volume, ranging from 1 to 16%. The residual signal of the OSLDs after 1 day bleached was within 1.5%. The accumulated and bleached OSLD signals had a standard deviation of ±?0.78 and ±?0.18 Gy, respectively. The TPS was found to underestimate the measured doses with deviations of 5% in OSLD, 17% in the Farmer ionisation chamber, and 7 and 8% for bladder and rectal diode probes. Discrepancies can be due to the positional uncertainty in the high-dose gradient. This demonstrates a slight displacement of the organ at risk near the steep dose gradient region will result in a large dose uncertainty. This justifies the importance of in vivo measurements in cobalt-60 HDR brachytherapy. 相似文献
876.
Kim Yong Hoon Her Ae-Young Rha Seung-Woon Choi Byoung Geol Choi Se Yeon Byun Jae Kyeong Mashaly Ahmed Park Yoonjee Jang Won Young Kim Woohyeun Choi Jah Yeon Park Eun Jin Na Jin Oh Choi Cheol Ung Lim Hong Euy Kim Eung Ju Park Chang Gyu Seo Hong Seog Oh Dong Joo 《Am J Cardiovasc Drugs》2018,18(2):117-127
American Journal of Cardiovascular Drugs - We aimed to evaluate the additive benefit of trimetazidine with well-known antispasmodic agents such as calcium channel blockers and nitrate in patients... 相似文献
877.
878.
Tacrolimus prevents von Willebrand factor secretion by allostimulated human glomerular endothelium 下载免费PDF全文
S. Béland O. Désy R. V. Ung P. Vallin E. Latulippe J. Riopel S. A. De Serres 《American journal of transplantation》2018,18(9):2314-2321
Little is known about the endothelial injury caused directly by circulating donor‐specific antibodies (DSAs) during antibody‐mediated rejection. von Willebrand factor (vWF) is a highly thrombotic glycoprotein stored in Weibel‐Palade bodies in endothelial cells. It has been shown that its secretion is triggered by allostimulation. Calcineurin‐like phosphatases regulate pathways involved in vWF secretion. Therefore, we hypothesized that tacrolimus would prevent alloantibody‐induced glomerular lesions, in part via inhibition of vWF secretion from endothelial cells. Here, we used a human in vitro model of glomerular endothelium expressing HLA class I and II antigens and demonstrated that anti–HLA class II antibodies elicit a higher endothelial release of vWF than do anti–HLA class I antibodies in cell supernatants. We observed that tacrolimus treatment decreased vWF secretion after stimulation with both classes of anti‐HLA antibodies and decreased platelet adhesion on allostimulated endothelial cells in a microfluidic chamber. In kidney recipients, tacrolimus trough levels were negatively associated with vWF blood levels. These results indicate that direct disruption of hemostasis via vWF secretion is a potential mechanism of antibody‐mediated injury in patients with DSAs. Our results further suggest that the targeting of microcirculation hemostasis may be beneficial to prevent the development of microangiopathic lesions in antibody‐mediated rejection. 相似文献
879.
880.
BACKGROUND: The ability to predict the behaviour of breast cancer from its dimensions allows the clinician to inform a woman about the absolute benefits of adjuvant therapies or further surgery to control her disease. Tumour size and grade are independent predictors of nodal disease. This study aims to generate a tool, using Australian data, allowing surgeons to calculate the probability of axillary lymph node involvement in a preoperative setting. METHODS: The histological reports of patients with breast cancer treated in 1995 in New South Wales were examined and tumour size, grade and nodal status recorded. Univariate and multivariate analyses identified predictors of node positivity and, using linear regression analysis, a simple formula to predict nodal involvement was derived. RESULTS: In a 6-month period, 754 women had non-metastatic, unifocal breast cancer treated with surgery and complete axillary dissection and 283 (37.5%) had positive nodes. Tumour size remained an independent predictor of node positivity and the probability (%), y, of nodal involvement may be predicted by the formula y = 1.5 x tumour size (mm) + 7, r = 0.939 and P = 0.001. CONCLUSIONS: This paper shows the need to assess the axilla in every patient because even patients with small tumours (0-5 mm) have the possibility of axillary involvement (7-14.5%). Use of this simple formula allows clinicians and patients to make informed decisions about the possible need for a full axillary dissection to reduce the chance of understaging and potentially undertreating a woman's breast cancer. 相似文献